ResearchRSS2 days ago
A large study found that children with Duchenne muscular dystrophy (DMD) who started taking corticosteroids—a type of anti-inflammatory medicine—earlier in life had better muscle strength and movement than children who started the medicine about a year later. This shows that starting treatment as soon as possible after diagnosis helps preserve how well kids can walk, run, and use their muscles.
WHY IT MATTERSIf you have a young child with DMD, this research provides strong evidence to discuss with your doctor about starting corticosteroid treatment immediately after diagnosis rather than waiting, as earlier treatment may significantly slow muscle weakness.
ResearchRSS3 days ago
Researchers found that data from smartphones and wearable devices, collected over several years through a health app, can help doctors identify people with a rare lung disease called idiopathic pulmonary arterial hypertension (IPAH) earlier than before. The study used information like heart rate and activity levels from the My Heart Counts app to spot differences between people with IPAH and healthy people. This discovery could lead to faster diagnosis of this serious condition.
WHY IT MATTERSEarlier detection of IPAH could allow patients to start treatment sooner, potentially slowing disease progression and improving outcomes for this condition that currently has no cure.
ResearchPUBMEDApr 16
Scientists created a new tool called STRIPE that uses advanced genetic testing to read long strands of RNA (the instructions cells use to make proteins). This tool can detect genetic mistakes that cause rare diseases by looking at how genes are actually working in cells, not just finding the mutations themselves. It's designed to be faster, cheaper, and more practical than older methods, which could help doctors diagnose rare genetic diseases that are hard to identify.
WHY IT MATTERSPatients with undiagnosed rare genetic diseases could finally get answers through more accurate genetic testing, since STRIPE can detect disease-causing variants that standard DNA tests might miss.
ResearchPUBMEDApr 14
Scientists discovered that cells found in urine can be grown in the lab and used to diagnose genetic diseases. These urine cells come from a specific part of the kidney called the glomerulus, and they have special properties that make them useful for testing. This method could make genetic diagnosis easier because urine is simple to collect compared to other tissue samples.
WHY IT MATTERSIf your child needs genetic testing for a rare disorder, this research suggests urine samples could eventually replace more invasive procedures like blood draws or biopsies for molecular diagnosis.
ResearchBIORXIVApr 14
Scientists created a new AI system called CoNVict that helps doctors figure out which genetic changes are actually causing rare diseases. Copy number variants (CNVs) are sections of DNA that are duplicated or missing, and they can cause genetic disorders, but it's hard to know which ones matter. This new tool uses artificial intelligence to automatically score and rank these genetic changes so doctors can focus on the ones most likely to be causing a patient's symptoms.
WHY IT MATTERSIf your child has unexplained developmental delays or birth defects and genetic testing found copy number variants, this AI tool could help doctors identify which variant is actually responsible for your child's condition, potentially speeding up diagnosis.
ResearchBIORXIVApr 2
Researchers discovered that mutations in a gene called THAP12 cause a severe type of childhood epilepsy called developmental and epileptic encephalopathy. Two siblings with this condition had two broken copies of the THAP12 gene (one from each parent), which stopped the gene from making enough of its protein. This finding helps explain why some children develop severe seizures early in life and could lead to better diagnosis and treatment options.
WHY IT MATTERSFamilies with children diagnosed with infantile spasms or Lennox-Gastaut syndrome now have a new genetic cause to test for, which could explain their child's condition and guide future treatment decisions.
ResearchBIORXIVApr 2
Researchers developed a new artificial intelligence system called GEN-KnowRD to help doctors recognize rare diseases faster and more accurately. Currently, patients with rare diseases wait years for a correct diagnosis because doctors don't have good tools to identify these uncommon conditions. This new AI system is designed to work better than previous attempts by using a smarter approach that doesn't require as much expert knowledge to keep updated.
WHY IT MATTERSFaster rare disease diagnosis could reduce the average diagnostic odyssey from years to months, allowing patients to access treatment and clinical trials earlier when interventions are most effective.
ResearchCONGRESSApr 1
Researchers studied how life circumstances like poverty, access to healthcare, and education affect children with developmental delays and intellectual disabilities. They also looked at how long it takes families to get a diagnosis and whether genetic testing helps. The study suggests that where you live and your resources matter a lot in getting answers for why a child has developmental challenges.
WHY IT MATTERSThis research highlights that children from disadvantaged backgrounds face longer diagnostic journeys for developmental delays—meaning families may wait years longer to understand their child's condition and access support services.
ResearchPUBMEDApr 1
Researchers in Italy tested a new way to diagnose rare genetic diseases in children using whole genome sequencing—a test that reads all of a person's genetic code. Between 2018 and 2022, they studied 64 children with complex neurological problems that doctors couldn't figure out. This study shows whether this genetic test could help find answers faster for kids with mysterious rare diseases.
WHY IT MATTERSIf your child has unexplained neurological symptoms and multiple doctors haven't found a diagnosis, this research demonstrates that whole genome sequencing through healthcare systems may finally provide answers—potentially ending years of diagnostic uncertainty.
ResearchPUBMEDApr 1
Researchers tested whether people could get genetic testing (genome sequencing) without always needing to see a genetics specialist first. They studied 313 people of all ages who had unexplained symptoms and could refer themselves or be referred by any doctor. The study found that people who referred themselves were just as likely to get a diagnosis as those referred by specialists. This suggests a new way to make genetic testing available to more people while still having genetics experts review the results.
WHY IT MATTERSIf this hybrid model works, patients with rare diseases could access genome sequencing faster and more easily without waiting for a genetics specialist appointment, potentially shortening the diagnostic odyssey that many rare disease patients experience.
ResearchPUBMEDMar 28
Scientists are getting better at finding rare genetic diseases using a tool called next-generation sequencing, which can read a person's DNA quickly and accurately. They're also developing new medicines called antisense oligonucleotides that can be customized for each patient to fix problems caused by genetic mutations. Together, these advances mean doctors can diagnose rare diseases faster and create personalized treatments tailored to each person's specific genetic makeup.
WHY IT MATTERSThis research shows a clear path for patients with rare genetic diseases to move from diagnosis to personalized treatment within a single medical framework, potentially reducing the diagnostic odyssey that currently takes years for many rare disease patients.
ResearchBIORXIVMar 27
Researchers studied how getting a genetic diagnosis through whole genome sequencing (a test that reads all of a person's genes) affects how much healthcare seriously ill children need over time. They looked at medical records from children in the UK between 2016 and 2020 to see if knowing the genetic cause of their illness changed how often they visited doctors, went to the hospital, or needed other medical care.
WHY IT MATTERSIf you have a seriously ill child undergoing genetic testing, this research will help show whether getting a diagnosis actually changes how your child's care is managed and how often you'll need medical visits going forward.
ResearchPUBMEDMar 26
Researchers in China studied 26 children and young adults (average age 8 years old) who had a rare cancer called rhabdomyosarcoma that started in the female reproductive organs. They tracked these patients for an average of nearly 5 years to see how well different treatments worked. This study helps doctors understand the best ways to treat this uncommon type of cancer in girls and young women.
WHY IT MATTERSThis is the first large study from China showing long-term survival rates for girls with genital rhabdomyosarcoma, which can help doctors worldwide improve treatment plans and give families more accurate information about what to expect.
ResearchPUBMEDMar 26
This study looked at how long it takes to diagnose APDS, a very rare immune system disorder that affects only 1-2 people per million. Researchers interviewed patients and doctors in Austria, Germany, and Switzerland and found that people typically wait several years before getting a correct diagnosis because the disease is so uncommon and looks different in different people.
WHY IT MATTERSPatients with APDS face years of diagnostic delay due to the disease's rarity and variable symptoms — understanding these barriers could help doctors recognize APDS faster and reduce the time families spend seeking answers.
ResearchPUBMEDMar 26
Researchers created DeepRare, a computer system that helps doctors diagnose rare diseases faster and more accurately. The system uses artificial intelligence to analyze patient information like symptoms, genetic test results, and medical history to suggest possible diagnoses. This could help patients avoid the long 'diagnostic odyssey' where they see many doctors over years before getting a correct diagnosis.
WHY IT MATTERSPatients with rare diseases spend an average of 5+ years seeking diagnosis with repeated misdiagnoses; DeepRare could dramatically shorten this timeline by providing doctors with AI-powered diagnostic support that integrates genetic and phenotype data.
ResearchPUBMEDMar 26
Shulman syndrome, also called eosinophilic fasciitis, is a rare disease where the tissue layers under the skin become thick and painful. This case describes a man whose condition started after minor injuries and spread throughout his body. Doctors confirmed the diagnosis using a deep skin biopsy and special imaging scans. This article helps doctors recognize unusual presentations of this rare disease.
WHY IT MATTERSThis case report documents an atypical presentation of Shulman syndrome that initially mimicked lymphedema on imaging, helping clinicians recognize and correctly diagnose this rare condition earlier to avoid delayed treatment.
ResearchCLINICALTRIALSMar 26
Researchers completed a study testing whether an AI tool called Legit.Health Plus can help doctors better diagnose rare and complicated skin conditions. The tool was tested with 15 healthcare providers to see if it could reduce the gap between what general doctors and skin specialists diagnose. This matters because conditions like Generalized Pustular Psoriasis and Hidradenitis Suppurativa can be missed or misdiagnosed, delaying proper treatment.
WHY IT MATTERSThis completed trial tested an AI diagnostic tool specifically designed to help primary care doctors accurately identify rare skin conditions like Generalized Pustular Psoriasis and Hidradenitis Suppurativa, which are often missed in non-specialist settings.
ResearchCLINICALTRIALSMar 26
Researchers are studying 1,000 children and adults with adrenocortical carcinoma (ACC), a rare cancer of the adrenal glands. They want to understand why some people survive longer than others and whether certain treatments work better. The average person with ACC lives about 14.5 months after diagnosis, but survival times vary widely.
WHY IT MATTERSThis study is actively collecting data that could help doctors better predict outcomes and choose more effective treatments for ACC patients, though it is not currently recruiting new participants.